Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

Gastritis III: Clinical Manifestations and Management

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pathology-Driven Epithelial Sulfide Loss Reprograms the Redox Proteome and Triggers Barrett's Esophagus.

Gastroenterology·2026

Same author

The Frequency of Dysplasia in Ultra-Short vs Conventional Barrett's Esophagus.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same author

A Pilot Study of Corticosteroid Treatment for Achalasia-Variant Esophagogastric Junction Outflow Obstruction.

Gastro hep advances·2026

Same author

Our New President-Byron L. Cryer, MD, AGAF.

Gastroenterology·2026

Same author

The Combined Utility of the CARS Endoscopic Score and Functional Lumen Imaging Probe (FLIP) Based on Real-Time Assessments.

Neurogastroenterology and motility·2026

Same author

Per-oral endoscopic myotomy (POEM) results in improvement in an endoscopic score for achalasia (the CARS Score).

Surgical endoscopy·2025

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Bringing GERD Management up to PAR-2.

The American Journal of Gastroenterology

|September 7, 2010

Summary

This summary is machine-generated.

Proton pump inhibitors heal reflux esophagitis but not heartburn. New GERD therapies may target immune pathways and proteinase-activated receptor-2 for better symptom relief.

More Related Videos

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver

Published on: August 27, 2021

Related Experiment Videos

Last Updated: Jun 9, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver

Published on: August 27, 2021

Area of Science:

Gastroenterology
Immunology
Pharmacology

Background:

Proton pump inhibitors (PPIs) are effective for healing reflux esophagitis but show limited efficacy in alleviating heartburn symptoms.
The prevailing assumption is that gastric acid is the primary cause of reflux esophagitis, leading to mucosal damage.
Emerging evidence indicates that immune-mediated mechanisms, triggered by reflux, play a significant role in esophagitis development.

Discussion:

This study challenges the sole focus on acid suppression in gastroesophageal reflux disease (GERD) treatment.
It highlights the potential contribution of immune responses in the esophageal mucosa during GERD.
The limitations of PPIs in managing heartburn symptoms warrant exploration of alternative therapeutic targets.

Key Insights:

Reflux esophagitis may involve immune-mediated pathways beyond direct acid injury.
Proteinase-activated receptor-2 (PAR-2) is implicated in immune-mediated esophageal damage and heartburn.
PPIs' effectiveness is primarily in mucosal healing, not symptom control for all GERD patients.

Outlook:

Future GERD therapies may target immune system components like PAR-2.
This approach could benefit patients with PPI-refractory GERD and persistent heartburn.
Investigating immune-mediated mechanisms offers a promising avenue for novel GERD treatments.